Frontlight ResearchEarly access
CompletedPhase 1
An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the pharmacokinetics of repeated doses of an approved antibiotic in healthy participants
Key facts
- Who runs it
- Cinclus Pharma Holding AB (publ)
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 12 people enrolled
- Started
- 11 Nov 2025
- Ended
- 22 Dec 2025
- Type of study
- Interventional
- Record updated
- 11 November 2025
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 11 November 2025